Načítá se...
CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation
SIMPLE SUMMARY: Chimeric antigen receptor (CAR)-T cell therapy has exhibited good application prospects in the treatment of hematologic malignancies. However, there are still many unsolved problems, such as the limited antitumor effect of CAR-T on solid tumors and the potential risk of CAR-T therapy...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8072891/ https://ncbi.nlm.nih.gov/pubmed/33921581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081955 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|